NexGel Inc Company Profile
NASDAQ: NXGLHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.176 -12.13%
NexGel at a glance
NexGel Inc (NASDAQ: NXGL) is a Medical/Dental Instruments company in the Health Care sector headquartered in Langhorne, PA. NexGel is led by Mr. Brian J. Kieser CPA and employs about 19 people. The company's shares have traded publicly since 2021.
At a market capitalization of $1.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001468929, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does NexGel do?
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Business description based on the company's public filings.
Company information
- Legal name
- NexGel Inc
- Ticker
- NASDAQ: NXGL
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Brian J. Kieser CPA
- Employees
- 19
- Headquarters
- 2150 Cabot Boulevard West, Langhorne, PA, United States
- Phone
- 215 702 8550
- Website
- nexgel.com
- IPO year
- 2021
- Market cap
- $1.46M
- SEC CIK
- 0001468929
- Latest annual report
- 10-K/A · Apr 30, 2026
Companies similar to NexGel
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GCTKGlucoTrack Inc. | 1.03 | -7.21% | $1.05M | vs NXGL |
| PFSAProfusa Inc. | 1.42 | -4.70% | $860.02K | vs NXGL |
| XAIRBeyond Air Inc. | 2.25 | -2.60% | $2.21M | vs NXGL |
| MMEDVMiniMed Group Inc. | 19.50 | -1.02% | — | vs NXGL |
| IVFINVO Fertility Inc. | 0.7275 | -2.28% | $3.35M | vs NXGL |
| ADGMAdagio Medical Holdings Inc | 0.13 | 0.00% | $3.53M | vs NXGL |
| BJDXBluejay Diagnostics Inc. | 0.8239 | +1.02% | $3.68M | vs NXGL |
| VVOSVivos Therapeutics Inc. | 0.1489 | -0.40% | $5.00M | vs NXGL |